Current research suggests that nitric oxide may play a role in the pathogenesis of neonatal meningitis. The related report by Mittal et al., "Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis," appears in the March 2010 issue of the American Journal of Pathology.
Bacterial meningitis, or inflammation of the membranes that cover the brain and spinal cord, is often fatal, even when treated with antibiotics. In neonates, mortality occurs in 25 percent to 35 percent of all patients, and long-term neurological and psychological effects are reported in up to 50 percent of survivors. One of the most common causes of neonatal meningitis is a serotype of Escherichia coli that expresses the capsular antigen K1, which is similar in structure to proteins expressed in the brain.
Nitric oxide plays a key role in the pathogenesis of meningitis; however, it remains unclear whether it plays a pro- or anti-microbial role. To determine the role of inducible nitric oxide synthase (iNOS), responsible for the production of nitric oxide, in meningitis, a group led by Dr. Nemani Prasadarao of the Children’s Hospital Los Angeles examined the effects of E. coli K1 infection in brains of neonatal mice. They found that E. coli K1 infection induced nitric oxide due to the activation of iNOS and that mice deficient in iNOS were resistant to E. coli infection. In addition, treatment with the iNOS-specific inhibitor aminoguanidine cleared the pathogen from circulation and prevented brain damage, likely via increased uptake and killing of bacteria by immune cells. Therefore iNOS inhibition may provide a new therapeutic strategy for treating neonatal E. coli-induced meningitis.
Mittal et al. conclude that "further understanding of the complex interactions between E. coli K1 and macrophages are important to the identification of novel interventional strategies that can improve the outcome of this deadly disease." Since these studies showed that the prevention of nitric oxide production by E. coli also suppressed the production of inflammatory cytokines, inhibition of nitric oxide might also be used as a therapeutic strategy for the prevention of sepsis. In future studies, Prasdarao and colleagues intend to "develop small molecule inhibitors that prevent the interaction of E. coli with its receptor on various cells and thereby reduce the production of nitric oxide."
This work was supported by a grant from the National Institutes of Health.
Reference: Mittal, R, Gonzalez-Gomez I, Goth KA, Prasadarao NV: Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis. Am J Pathol 176:1292-1305.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
The Key to Sterile Processing Success: Leadership Engagement and Team Collaboration
January 24th 2025Effective sterile processing leadership requires active engagement, clear communication, and a transformational approach to foster collaboration, accountability, and quality in infection prevention and surgical instrument management.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Environmental Hygiene: Air Pressure and Ventilation: Negative vs Positive Pressure
December 10th 2024Learn more about how effective air pressure regulation in health care facilities is crucial for controlling airborne pathogens like tuberculosis and COVID-19, ensuring a safer environment for all patients and staff.